Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oncorus Inc (ONCR)

Oncorus Inc (ONCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oncorus Inc 4 Corporate Drive Andover MA 01810 USA

www.oncorus.com P: 339-240-3330

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Oncorus Inc. is a clinical stage biopharmaceutical company. It is focused on developing viral immunotherapies to transform outcomes for cancer patients. The company's product candidate includes ONCR-177, which is in clinical stage. Oncorus Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 3,288
Enterprise Value, $K -2,982
Shares Outstanding, K 26,095
Float, K 21,633
% Float 82.90%
Short Volume Ratio 0.10
% of Insider Shareholders 17.10%
% of Institutional Shareholders 20.07%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -77,420 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -30,900 K
EBIT, $ -88,420 K
EBITDA, $ -85,070 K

Growth:

1-Year Return -50.63%
3-Year Return -99.61%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.18 on 05/22/23
Next Earnings Date 03/22/24
Earnings Per Share ttm -3.49
EPS Growth vs. Prev Qtr -45.68%
EPS Growth vs. Prev Year -71.01%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ONCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.66
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.11
Book Value/Share 1.19
Interest Coverage -2.55
60-Month Beta 1.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar